John Hussman's AMGN Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 8,400 shares of Amgen Inc. (AMGN) worth $2.75 M, representing 0.66% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 41 quarters.
Based on 13F filings since 2013, John Hussman has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2013, adding 50,000 shares. Largest reduction occurred in Q2 2014, reducing 100,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +8,400 | New Buy | 8,400 | $327.31 |
| Q1 2025 | -14,700 | Sold Out | 0 | $0.00 |
| Q4 2024 | +4,200 | Add 40.00% | 14,700 | $260.64 |
| Q3 2024 | -2,100 | Reduce 16.67% | 10,500 | $322.21 |
| Q2 2024 | +2,100 | Add 20.00% | 12,600 | $312.45 |
| Q1 2024 | +4,200 | Add 66.67% | 10,500 | $284.32 |
| Q4 2023 | -9,450 | Reduce 60.00% | 6,300 | $288.02 |
| Q3 2023 | +150 | Add 0.96% | 15,750 | $268.76 |
| Q2 2023 | +100 | Add 0.65% | 15,600 | $222.02 |
| Q4 2022 | -3,100 | Reduce 16.67% | 15,500 | $262.64 |
| Q3 2022 | +8,250 | Add 79.71% | 18,600 | $225.38 |
| Q2 2022 | +2,550 | Add 32.69% | 10,350 | $243.29 |
| Q1 2022 | -2,600 | Reduce 25.00% | 7,800 | $241.79 |
| Q4 2021 | +1,100 | Add 11.83% | 10,400 | $225.00 |
| Q2 2021 | -5,100 | Reduce 35.42% | 9,300 | $243.76 |
| Q1 2021 | +2,100 | Add 17.07% | 14,400 | $248.82 |
| Q4 2020 | +7,200 | Add 141.18% | 12,300 | $229.92 |
| Q3 2020 | +5,100 | New Buy | 5,100 | $254.12 |
| Q2 2020 | -15,500 | Sold Out | 0 | $0.00 |
| Q1 2020 | +15,500 | New Buy | 15,500 | $202.71 |
| Q4 2019 | -5,250 | Sold Out | 0 | $0.00 |
| Q3 2019 | +250 | Add 5.00% | 5,250 | $193.52 |
| Q2 2019 | -15,000 | Reduce 75.00% | 5,000 | $184.20 |
| Q4 2018 | +20,000 | New Buy | 20,000 | $194.65 |
| Q4 2016 | -900 | Sold Out | 0 | $0.00 |
| Q4 2015 | -39,100 | Reduce 97.75% | 900 | $162.22 |
| Q3 2015 | +40,000 | New Buy | 40,000 | $138.32 |
| Q1 2015 | -25,000 | Sold Out | 0 | $0.00 |
| Q3 2014 | -25,000 | Reduce 50.00% | 25,000 | $140.48 |
| Q2 2014 | -100,000 | Reduce 66.67% | 50,000 | $118.36 |
| Q1 2014 | -25,000 | Reduce 14.29% | 150,000 | $123.34 |
| Q4 2013 | -75,000 | Reduce 30.00% | 175,000 | $114.16 |
| Q3 2013 | +50,000 | Add 25.00% | 250,000 | $111.94 |
| Q2 2013 | +200,000 | Add 0.00% | 200,000 | $98.66 |
John Hussman's Amgen Investment FAQs
John Hussman first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 200,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Amgen Inc. (AMGN) for 41 quarters since Q2 2013.
John Hussman's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 200,000 shares worth $19.73 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 8,400 shares of Amgen Inc. (AMGN), valued at approximately $2.75 M.
As of the Q4 2025 filing, Amgen Inc. (AMGN) represents approximately 0.66% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Amgen Inc. (AMGN) was 250,000 shares, as reported at the end of Q3 2013.